Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
暂无分享,去创建一个
M. Górska | S. Tucker | K. Honn | M. Wojtukiewicz | M. Moniuszko | P. Radziwon | B. Politynska | Anna M. Wojtukiewicz | Magdalena Rek | Kamil Karpowicz